Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo)
- Balazs Halmos
- , Eng Huat Tan
- , Ross A. Soo
- , Jacques Cadranel
- , Min Ki Lee
- , Pascal Foucher
- , Te Chun Hsia
- , Maximilian Hochmair
- , Frank Griesinger
- , Toyoaki Hida
- , Edward Kim
- , Barbara Melosky
- , Angela Märten
- , Enric Carcereny
Research output: Contribution to journal › Article › peer-review
74
Link opens in a new tab
Scopus
citations